Polaryx Therapeutics, Inc. Common Stock (PLYX) Financials
PLYX Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 11.8 million | 873000 |
| March 31, 2026 | 3.5 million | 1.0 million |
| Dec. 31, 2025 | 5.4 million | 855000 |
| Sept. 30, 2025 | 6.0 million | 682000 |
PLYX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | ? | ? |
| March 31, 2026 | -2.1 million | 467000 |
| Dec. 31, 2025 | -1.5 million | 57000 |
| Sept. 30, 2025 | -887000 | 108000 |
PLYX Net Income
No data available :(
PLYX Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 11.5 million | - | - |
| March 31, 2026 | 3.1 million | - | - |
| Dec. 31, 2025 | 5.1 million | - | - |
| Sept. 30, 2025 | 5.7 million | - | - |
PLYX Shares Outstanding
PLYX Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | - | 719000 | - | - |
| March 31, 2026 | - | 679000 | 1.3 million | - |
| Dec. 31, 2025 | - | 560000 | 351000 | - |
| Sept. 30, 2025 | - | 514000 | 460000 | - |
PLYX Cost of Revenue
No data available :(
PLYX
Price: $2.07
52 week price:
Earnings Per Share: -0.14 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 98.9 million